52. Diabetic patients
(n = 12,074; 35,545 fundus
examinations)
The time from onset of retinopathy to clinical diagnosis of diabetes
was calculated as a point estimate by extrapolating the intercept of
the best-fitting regression line with the horizontal axis.
2014 DC Estimating the Delay Between Onset and Diagnosis of Type 2 Diabetes From the Time Course of Retinopathy Prevalence
53. 2014 DC Estimating the Delay Between Onset and Diagnosis of Type 2 Diabetes From the Time Course of Retinopathy Prevalence
72. Anti-hypertensive
prescriptions
(2008-2011)
N = 8,315,709
New users
N = 2,357,908
Age ≥ 50 yrs
Monotherapy
Compliant user (MPR≥80%)
No previous fracture
N = 528,522
Prevalent users
N = 5,957,801
Excluded
Age <50
Combination therapy
Inadequate compliance
Previous fracture
N = 1,829,386
Final study population
심평원 빅데이터 연구
고혈압약과 골절
Choi et al., in revision
74. 2008-2011 Prescriptions
N = 2,886,555
New Users
N = 718,293
Monotherapy+Combination (MPR>80%)
Age > 50 yrs
No previous fracture
N = 208,648
심평원 빅데이터 연구
당뇨병약과 골절
75. Total
0 200 400 600
Metformin+DPP4i
SU+TZD
Metformin+TZD
Metformin+SU
AGI
SU
Metformin
Non-user
Fracture Rates per 10,000 Person-Years
Female
0 200 400 600
Metformin+DPP4i
SU+TZD
Metformin+TZD
Metformin+SU
AGI
SU
Metformin
Non-user
Fracture Rates per 10,000 Person-Years
Fracture Rates
(per 10,000 Person-Years)
0 200 400 600
Metformin+DPP4i
SU+TZD
Fracture Rates per 10,000 Person-Years
Male
0 200 400 600
Metformin+DPP4i
SU+TZD
Metformin+TZD
Metformin+SU
AGI
SU
Metformin
Non-user
Fracture Rates per 10,000 Person-Years
Total
Male
Female